Medical Health & Life Science Research News

New report shares details about the 2.9% CAGR cancer diagnostics market size to hit $13.1 billion

Cancer Diagnostics Market analyzes and studies the major market drivers, restraints, and opportunities.

- Advertising -

The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, cancer diagnostics market growing at a CAGR of 12.9%. 

North America accounted for the largest share of the global cancer diagnostics market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cancer diagnostics market is expected to experience the highest growth rate in the Asian region, with emphasis on India and China.

These countries are expected to serve as revenue pockets for companies operating in the cancer diagnostics market. Inquire For Complete Report Copy of Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020 at…aspx?name=402128

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms, garner a greater market share.

- Advertising -

According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths.

The global Cancer Diagnostics Market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR). 

“Cancer Diagnostics Market” spread across 187 pages, profiling 15 companies and supported with 119 tables and 33 figures is now available at…aspx?name=402128

Some of the major players in the global cancer diagnostics market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.),  GE Healthcare (U.K.), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.). 

Key Point from Table of Content 

Global Cancer Diagnostics Market, By Technology
Platform-Based Diagnostics
Polymerase Chain Reaction (PCR)
in Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Flow Cytometry
Other Technologies
Diagnostic Imaging
Magnetic Resonance Imaging (MRI)
Computed Tomography (Ct)
Positron Emission Tomography (PET)
Standalone Positron Emission Tomography
Hybrid Positron Emission Tomography

Global Cancer Diagnostics Market, By Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Other Cancers 

Access this Report @

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany about: provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. Email us at This email address is being protected from spambots. You need JavaScript enabled to view it..
This email address is being protected from spambots. You need JavaScript enabled to view it.